Literature DB >> 505430

A hemostasis activating factor (HAF) in subcutaneous tissue extracts: effects on morphologic platelet changes, platelet retention and platelet aggregation.

C Kirchmaier, N Bender, B Wilhelm, A A Sayegh, K Breddin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 505430     DOI: 10.1016/0049-3848(79)90271-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

1.  Plasma drug and antiplatelet profiles of the original acetylsalicylic acid preparations used in the AMIS, PARIS and German-Austrian trials for secondary prevention of myocardial infarction.

Authors:  R Simrock; K Rehders; H Spahn; E Mutschler; H K Breddin
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Haemostasis during treatment with ciprofloxacin.

Authors:  M Ziemen; P M Shah; K Breddin
Journal:  Infection       Date:  1988       Impact factor: 3.553

3.  [Reversible inhibition of thrombocyte stimulation by acetylsalicylic acid and its role in antithrombotic therapy].

Authors:  R Simrock; H Spahn; H K Breddin; E Mutschler
Journal:  Klin Wochenschr       Date:  1983-03-15

4.  [Effects of acetylsalicylic acid on partial functions of human thrombocytes are not inhibited in vivo by salicylic acid].

Authors:  R Simrock; V Lischke; A Missalla; P Schwidtal; H K Breddin
Journal:  Klin Wochenschr       Date:  1984-03-01

5.  Plasma salicylate levels and platelet function after acute and chronic administration of slow-release acetylsalicylic acid (Monobeltin).

Authors:  K Rehders; R Simrock; H Spahn; E Mutschler; H K Breddin
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study.

Authors:  Ryo Kubota; Chirag Jhaveri; John M Koester; Jeffrey K Gregory
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-27       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.